Stock Report

All about this stock under one free report Last Updated: 23-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Jagsonpal Pharma Peer Comparison

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: JAGSNPHARM | BSE: 507789

₹226.44

up-down-arrow ₹0.76 (0.34%)

As on 23-Sep-2026 10:24IST

Market cap

info icon

₹1,495 Cr

Revenue (TTM)

info icon

₹294 Cr

P/E Ratio

info icon

32.9

P/B Ratio

info icon

6.5

Div. Yield

info icon

2.4 %

Edit peer-selector-edit
Jagsonpal Pharma Caplin Point Lab Shilpa Medicare Eris Lifesciences Pfizer
Market cap (₹ Cr)
 1,495 21,397 20,424 17,619 18,349
Revenue (₹ Cr)
 294 2,287 1,682 3,230 2,570
Net Profit (₹ Cr)
 45.48 678.07 273.51 666.92 735.15
Net Margin (%)
 14.87 28.10 16.19 20.60 26.88
RoE (%)
 17.79 19.73 11.15 18.75 19.16
Price to Earnings
 32.88 32.16 68.69 27.36 24.96
Price-To-Book
 6.49 5.83 7.60 4.37 4.16

Income Statement (₹ Cr)

Jagsonpal Pharma Caplin Point Lab Shilpa Medicare Eris Lifesciences Pfizer
Operating Revenue arrow
293.85 2,287.33 1,682.47 3,229.67 2,569.77
Total Income arrow
305.85 2,413.29 1,689.83 3,237.12 2,735.39
Total Expenditure arrow
232.74 1,490.75 1,203.91 2,090.06 1,628.14
EBITDA arrow
61.10 796.58 478.55 1,139.61 941.63
Depreciation arrow
9.23 78.10 126.01 281.06 57.58
EBIT arrow
51.87 718.48 352.55 858.55 884.05
Interest arrow
1.03 0.88 52.11 190.64 7.69
Other Income arrow
12.00 125.96 7.37 7.45 165.62
Exceptional Items arrow
-2.08 0.00 12.16 -17.24 -49.16
Profit before Tax arrow
60.77 843.56 319.96 658.12 992.82
Provision for Tax arrow
15.29 165.49 46.45 -8.80 257.67
Profit after Tax arrow
45.48 678.07 273.51 666.92 735.15

Liabilities (₹ Cr)

Jagsonpal Pharma Caplin Point Lab Shilpa Medicare Eris Lifesciences Pfizer
Shareholder's Funds arrow
276.17 3,586.42 2,591.20 3,902.67 4,202.90
Minority Interest arrow
0.00 -12.71 0.00 -21.81 0.00
Non-Current Liabilities arrow
12.21 28.74 266.35 1,392.75 91.50
Current Liabilities arrow
28.30 385.94 848.06 2,077.10 627.48
Total Liabilities arrow
329.30 4,037.51 3,705.61 7,246.72 4,921.88

Assets (₹ Cr)

Jagsonpal Pharma Caplin Point Lab Shilpa Medicare Eris Lifesciences Pfizer
Non-Current Assets arrow
78.53 1,291.22 2,525.44 5,617.77 770.28
Current Assets arrow
143.09 2,585.66 1,109.77 1,539.85 3,803.22
Total Assets arrow
329.30 4,037.51 3,705.61 7,246.72 4,921.88
Total Debt* arrow
0.00 0.57 657.97 2,309.68 2.50
Net Current Assets arrow
114.79 2,199.72 261.71 -537.25 3,175.74
Contingent Liabilities arrow
22.34 17.53 160.01 51.57 370.49

Cashflow (₹ Cr)

Jagsonpal Pharma Caplin Point Lab Shilpa Medicare Eris Lifesciences Pfizer
Cash From Operating Activities arrow
46.81 523.24 342.18 537.99 967.57
Cash Flow from Investing Activities arrow
-35.65 -582.30 -325.92 -369.46 -561.67
Cash from Financing Activities arrow
-12.15 -46.46 13.62 -313.53 -798.31
Net Cash Inflow / Outflow arrow
-0.99 -105.52 29.88 -145.00 -392.41

Ratios

Profitability Ratios

 Jagsonpal Pharma Caplin Point Lab Shilpa Medicare Eris Lifesciences Pfizer
ROCE (%) arrow
22.69 24.97 11.43 14.47 23.39
ROE (%) arrow
17.79 19.73 11.15 18.75 19.16
ROA (%) arrow
15.29 18.69 7.80 9.26 14.95
EBIT Margin (%) arrow
17.65 31.41 20.95 26.58 34.40
Net Margin (%) arrow
14.87 28.10 16.19 20.60 26.88
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Jagsonpal Pharma Caplin Point Lab Shilpa Medicare Eris Lifesciences Pfizer
Revenue Growth (%) arrow
3.87 15.01 27.91 9.59 10.69
EBIT Growth (%) arrow
13.66 18.45 58.32 16.84 24.14
Net Profit Growth (%) arrow
-25.24 19.61 149.56 62.68 -9.09
EPS Growth (%) arrow
-20.48 17.73 -3.57 67.41 14.40
Book Value Growth (%) arrow
17.30 26.75 9.67 36.71 -0.34

Valuation Ratios

 Jagsonpal Pharma Caplin Point Lab Shilpa Medicare Eris Lifesciences Pfizer
Price / Earnings arrow
31.94 31.75 72.10 26.76 23.69
Price / Book Value arrow
6.47 5.75 7.52 4.38 4.15
Dividend Yield (%) arrow
2.43 0.29 0.06 0.00 1.88
EV/EBITDA arrow
22.65 25.26 43.51 17.46 16.11
Market Cap (₹ Cr) arrow
1,234.49 11,439.22 6,819.66 17,980.08 21,592.90

Solvency Ratios

 Jagsonpal Pharma Caplin Point Lab Shilpa Medicare Eris Lifesciences Pfizer
Debt to Equity arrow
0.00 0.00 0.07 0.24 0.00
Short term debt to equity ratio arrow
-- 0.00 0.16 0.12 0.00
Current Ratio arrow
5.06 6.70 1.31 0.74 6.06
Quick Ratio arrow
4.54 5.59 0.88 0.53 5.31
Interest Coverage arrow
60.28 959.59 7.14 4.45 130.11

Operating Efficiency Ratios

 Jagsonpal Pharma Caplin Point Lab Shilpa Medicare Eris Lifesciences Pfizer
Debtors to sales (%) arrow
5.85 36.10 30.84 21.07 7.07
Asset Turnover arrow
0.99 0.63 0.48 0.45 0.52
Receivable days arrow
18.20 121.68 113.81 63.88 26.06
Inventory Days arrow
17.89 63.83 84.76 43.27 65.95
Payable days arrow
37.27 108.28 101.94 151.85 81.01
Cash Conversion Cycle arrow
-1.18 77.23 96.62 -44.70 11.00
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...